144 related articles for article (PubMed ID: 36877087)
1. Unravelling the destabilization potential of ellagic acid on α-synuclein fibrils using molecular dynamics simulations.
Mankoo OK; Kaur A; Goyal D; Goyal B
Phys Chem Chem Phys; 2023 Mar; 25(11):8128-8143. PubMed ID: 36877087
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface.
Yao Y; Tang Y; Wei G
ACS Chem Neurosci; 2020 Dec; 11(24):4351-4361. PubMed ID: 33186020
[TBL] [Abstract][Full Text] [Related]
3. Effect of flavonoids on the destabilization of α-synuclein fibrils and their conversion to amorphous aggregate: A molecular dynamics simulation and experimental study.
Jahan I; Ahmad A; Deep S
Biochim Biophys Acta Proteins Proteom; 2023 Nov; 1871(6):140951. PubMed ID: 37574034
[TBL] [Abstract][Full Text] [Related]
4. Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of α-Synuclein: Implications for Parkinson's Disease.
Meena VK; Kumar V; Karalia S; Garima ; Sundd M
ACS Chem Neurosci; 2021 Oct; 12(19):3598-3614. PubMed ID: 34506119
[TBL] [Abstract][Full Text] [Related]
5. Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy.
Ardah MT; Eid N; Kitada T; Haque ME
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948195
[TBL] [Abstract][Full Text] [Related]
6. Baicalein exhibits differential effects and mechanisms towards disruption of α-synuclein fibrils with different polymorphs.
Yao Y; Tang Y; Zhou Y; Yang Z; Wei G
Int J Biol Macromol; 2022 Nov; 220():316-325. PubMed ID: 35981677
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Insight into the Binding Profile of DCVJ and α-Synuclein Fibril Revealed by Multiscale Simulations.
Kuang G; Murugan NA; Ågren H
ACS Chem Neurosci; 2019 Jan; 10(1):610-617. PubMed ID: 30277753
[TBL] [Abstract][Full Text] [Related]
8. Unveiling How Hydroxytyrosol Destabilizes α-Syn Oligomers Using Molecular Simulations.
Kaur G; Mankoo OK; Goyal D; Goyal B
J Phys Chem B; 2023 Jun; 127(25):5620-5632. PubMed ID: 37319389
[TBL] [Abstract][Full Text] [Related]
9. Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson's Disease.
Radwan N; Khan E; Ardah MT; Kitada T; Haque ME
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201915
[TBL] [Abstract][Full Text] [Related]
10. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study.
Sanjeev A; Mattaparthi VSK
Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628
[TBL] [Abstract][Full Text] [Related]
11. Ellagic Acid Inhibits α-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity.
Kumar S; Kumar R; Kumari M; Kumari R; Saha S; Bhavesh NS; Maiti TK
ACS Chem Neurosci; 2021 Jun; 12(11):1919-1930. PubMed ID: 34015214
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.
Zhao K; Lim YJ; Liu Z; Long H; Sun Y; Hu JJ; Zhao C; Tao Y; Zhang X; Li D; Li YM; Liu C
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20305-20315. PubMed ID: 32737160
[TBL] [Abstract][Full Text] [Related]
13. Naphthoquinone-dopamine hybrids disrupt α-synuclein fibrils by their intramolecular synergistic interactions with fibrils and display a better effect on fibril disruption.
Zhou Y; Yao Y; Yang Z; Tang Y; Wei G
Phys Chem Chem Phys; 2023 May; 25(20):14471-14483. PubMed ID: 37190853
[TBL] [Abstract][Full Text] [Related]
14. Critical nucleus of Greek-key-like core of α-synuclein protofibril and its disruption by dopamine and norepinephrine.
Zou Y; Qian Z; Gong Y; Tang Y; Wei G; Zhang Q
Phys Chem Chem Phys; 2019 Dec; 22(1):203-211. PubMed ID: 31799519
[TBL] [Abstract][Full Text] [Related]
15. How oxidized EGCG remodels α-synuclein fibrils into non-toxic aggregates: insights from computational simulations.
Gonçalves PB; Palhano FL; Cordeiro Y; Sodero ACR
Phys Chem Chem Phys; 2023 Jul; 25(28):19182-19194. PubMed ID: 37431676
[TBL] [Abstract][Full Text] [Related]
16. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
[TBL] [Abstract][Full Text] [Related]
17. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
[TBL] [Abstract][Full Text] [Related]
18. Nitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson's Disease.
Chavarría C; Trostchansky A; Durán R; Rubbo H; Souza JM
Adv Exp Med Biol; 2019; 1127():169-179. PubMed ID: 31140178
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins.
Jain MK; Singh P; Roy S; Bhat R
Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342
[TBL] [Abstract][Full Text] [Related]
20. Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
Nahass GR; Sun Y; Xu Y; Batchelor M; Reilly M; Benilova I; Kedia N; Spehar K; Sobott F; Sessions RB; Caughey B; Radford SE; Jat PS; Collinge J; Bieschke J
J Mol Biol; 2021 Apr; 433(8):166878. PubMed ID: 33610557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
